These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38035312)

  • 21. Pharmacist recommendations to improve the quality of diabetes care: a randomized controlled trial.
    Kirwin JL; Cunningham RJ; Sequist TD
    J Manag Care Pharm; 2010 Mar; 16(2):104-13. PubMed ID: 20178395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the Addition of Pharmacist Management to a Medication Assistance Program in Patients with Hypertension and Diabetes Resistant to Usual Care.
    Smith AM; Hamann GL; Campbell JD; Sprabery LR
    J Pharm Pract; 2022 Aug; 35(4):606-611. PubMed ID: 33739190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycemic control and preventive care measures of indigent diabetes patients within a pharmacist-managed insulin titration program vs standard care.
    Salvo MC; Brooks AM
    Ann Pharmacother; 2012 Jan; 46(1):29-34. PubMed ID: 22202497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maintenance of Goal Blood Pressure, Cholesterol, and A1C Levels in Veterans With Type 2 Diabetes After Discharge From a Pharmacist-Managed Ambulatory Care Clinic.
    Erwin PB; Pitlick MK; Peters GL
    Diabetes Spectr; 2015 Nov; 28(4):237-44. PubMed ID: 26600724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real-World Glycemic Control from GLP-1RA Therapy with and Without Concurrent Insulin in Patients with Type 2 Diabetes.
    Singhal M; Unni S; Schauerhamer M; Nguyen H; Hurd J; McAdam-Marx C
    J Manag Care Spec Pharm; 2017 Mar; 23(3):267-275. PubMed ID: 28230449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease.
    Spence MM; Makarem AF; Reyes SL; Rosa LL; Nguyen C; Oyekan EA; Kiyohara AT
    J Manag Care Spec Pharm; 2014 Oct; 20(10):1036-45. PubMed ID: 25278326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maintenance of Clinical Endpoints After Discharge from a Pharmacist-Managed Risk Reduction Clinic at a Veterans Affairs Medical Center.
    Sherrill CH; Pentecost A; Wood EE
    J Manag Care Spec Pharm; 2016 Jan; 22(1):14-20. PubMed ID: 27015047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of care of a pharmacist-managed diabetes service compared to usual care in an indigent clinic.
    Irons BK; Seifert CF; Horton NA
    Diabetes Technol Ther; 2008 Jun; 10(3):220-6. PubMed ID: 18473697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing Clinical Outcomes of a Pharmacist-Managed Diabetes Clinic to Usual Physician-Based Care.
    Schultz JL; Horner KE; McDanel DL; Miller ML; Beranek RL; Jacobsen RB; Sly NJ; Miller AC; Mascardo LA
    J Pharm Pract; 2018 Jun; 31(3):268-271. PubMed ID: 28532224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of clinical pharmacy specialists and usual care in outpatient management of hyperglycemia in Veterans Affairs medical centers.
    Ourth HL; Hur K; Morreale AP; Cunningham F; Thakkar B; Aspinall S
    Am J Health Syst Pharm; 2019 Jan; 76(1):26-33. PubMed ID: 31381096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved Glycemic Control Outcomes Regardless of Mental Health Disorders in a Pharmacist-Endocrinologist Diabetes Intense Medical Management (DIMM) "Tune Up" Clinic.
    Morello CM; Nguyen T; Tao L; Hirsch JD
    Ann Pharmacother; 2020 Sep; 54(9):858-865. PubMed ID: 32100551
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacist-provided diabetes management and education via a telemonitoring program.
    Shane-McWhorter L; McAdam-Marx C; Lenert L; Petersen M; Woolsey S; Coursey JM; Whittaker TC; Hyer C; LaMarche D; Carroll P; Chuy L
    J Am Pharm Assoc (2003); 2015; 55(5):516-26. PubMed ID: 26359961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of clinical pharmacist management of lipid-lowering therapy in a primary care setting.
    Till LT; Voris JC; Horst JB
    J Manag Care Pharm; 2003; 9(3):269-73. PubMed ID: 14613471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a pharmacist-managed amiodarone monitoring program.
    Spence MM; Polzin JK; Weisberger CL; Martin JP; Rho JP; Willick GH
    J Manag Care Pharm; 2011 Sep; 17(7):513-22. PubMed ID: 21870892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of pharmacist managed oral epidermal growth factor receptor inhibitors.
    Ng S; Baker N; Niu F; Katzel JA; Bergere HT; Whang M; McGary E; Liu R; Le K; Hui RL
    J Oncol Pharm Pract; 2024 Jul; ():10781552241265891. PubMed ID: 39042924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of a clinical pharmacy anemia management service on adherence to monitoring guidelines, clinical outcomes, and medication utilization.
    Debenito JM; Billups SJ; Tran TS; Price LC
    J Manag Care Spec Pharm; 2014 Jul; 20(7):715-20. PubMed ID: 24967524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of pharmacist-led care on glycaemic control of patients with uncontrolled type 2 diabetes: a randomised controlled trial in Nigeria.
    David EA; Soremekun RO; Abah IO; Aderemi-Williams RI
    Pharm Pract (Granada); 2021; 19(3):2402. PubMed ID: 34457094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the Impact of a Pharmacist-Led Telehealth Clinic on Diabetes-Related Goals of Therapy in a Veteran Population.
    Maxwell LG; McFarland MS; Baker JW; Cassidy RF
    Pharmacotherapy; 2016 Mar; 36(3):348-56. PubMed ID: 26877253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycemic Control and Management in Pharmacist-Led Diabetic Clinic vs. Physician-Led Diabetic Clinic.
    Alghadeer SM; Alsuwayni B; Almuwayjid AK; Almadi MS; Mubarak AM; Khunayn RMB; Al-Arifi MN
    Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056322
    [No Abstract]   [Full Text] [Related]  

  • 40. Impact of a clinical pharmacist on provider prescribing patterns in a primary care clinic.
    Wei ET; Gregory P; Halpern DJ; Felton M; Goldstein BA; Yeatts J; Shah K; Smith BH
    J Am Pharm Assoc (2003); 2022; 62(1):209-213.e1. PubMed ID: 34756524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.